Exome Asset Management LLC Pliant Therapeutics, Inc. Transaction History
Exome Asset Management LLC
- $115 Billion
- Q2 2024
A detailed history of Exome Asset Management LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 124,000 shares of PLRX stock, worth $1.38 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
124,000Holding current value
$1.38 Million% of portfolio
1.16%Shares
2 transactions
Others Institutions Holding PLRX
# of Institutions
158Shares Held
63.8MCall Options Held
481KPut Options Held
105K-
Deep Track Capital, LP Greenwich, CT5.97MShares$66.4 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$55.3 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.6MShares$51.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$38.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.4MShares$37.8 Million3.33% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $541M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...